Navigation Links
Pharma IQ's Drug Recalls Industry Outline
Date:8/24/2012

LONDON, August 24, 2012 /PRNewswire/ --

Pharma IQ has just produced the Drug Recalls Industry Outline, where it analyses the challenges and implications of the late stage development failures. Pharma IQ had a quick look back over the last few years to see a timeline of drug failures and recalls at the late stages of development.

'Some of the key time saving strategies and information sources to make these decisions are trial design approaches, imaging techniques, biomarkers, strategic outsourcing and patient recruitment' says Nicola Ambler, Senior Conference Director, Pharma IQ, who is directing the upcoming Innovation in Phase 1 Clinical Development in Milan this September.

The outline analyses the drug withdrawals in the latter stages. In August 2012, Pfizer and J&J announced they were going to stop the development of the Alzheimer's drug, Bapineuzumab.  In March 2012 AstraZeneca and Targacept announced that their partnered depression drug - TC-5214 - failed at Phase III. The last two of four late-stage studies failed to meet their primary endpoints, eliminating plans for a comeback after the first two Phase III studies also ended in failure. In March 2011 Sanofi-Aventis' lung cancer drug aflibercept failed to meet its primary endpoint in a phase III trial.

The Drug Recalls Industry Outline can be accessed at http://www.phase1clinicaldevelopment.com/news

The Industry Outline was created as a part of the pre-conference preparation for the 3th Innovation in Phase I Clinical Development Forum taking place 17-19 September, 2012 in Milan. The agenda and final speaker line-up feature JW McBlane, Pharmaceutical Assessor, MHRA that will lead the session Early Clinical Studies - A Regulator's Expectations for Complex Protocols a
'/>"/>

SOURCE Pharma IQ
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
2. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
3. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
4. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
5. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
6. Academy of Managed Care Pharmacy (AMCP) Installs 2012-2013 Board of Directors
7. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
8. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
9. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
10. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
11. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... , Apr. 17, 2015 Steven Rash ... ALGA ), and its operating subsidiary American Seed & ... exclusive presentation to investors yesterday in New York City.  ... The American Seed & Oil Company has ... Hippie Butter Hemp Seed Foods , the ...
(Date:4/17/2015)... Apr. 16, 2015 Research and Markets ... "Corporate Reputation of Pharma in 2014 - a ... report to their offering. This independent study, ... patient groups with an interest in diabetes on the ... the pharma industry as a whole) in 2014. The ...
(Date:4/17/2015)... Research and Markets ( http://www.researchandmarkets.com/research/kh5kqg/the_corporate ... "The Corporate Reputation of Pharma - The Patient ... report to their offering. The Corporate ... in its fourth edition. This report contains the ... each annual Corporate Reputation report, the author surveys ...
Breaking Medicine Technology:American Seed & Oil Company Benchmarks its Consumer Product Development Strategy Against Proctor & Gamble 2American Seed & Oil Company Benchmarks its Consumer Product Development Strategy Against Proctor & Gamble 3Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 2Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 3Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 4Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 5The Corporate Reputation of Pharma - The Global Patient Perspective in 2014 2
... Switzerland, April 3, 2007 (PRIME NEWSWIRE) -- ... and,pharmacokinetic profiles of Basilea's (SWX:BSLN) two late-stage,drug ... ceftobiprole, the first anti-MRSA broad-spectrum,cephalosporin in late-stage ... the treatment of invasive fungal infections,yielded further ...
... 4, 2007 - CytRx Corporation,(NASDAQ:CYTR) today announced ... that CytRx's lead drug candidate,arimoclomol significantly accelerated ... an experimental rat model of stroke, even ... hours after stroke was,induced. These data confirm ...
Cached Medicine Technology:Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 2Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 3Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 4Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 5Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 6Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 7CytRx Announces Positive Results of Arimoclomol in Preclinical,Stroke Recovery Studies 2CytRx Announces Positive Results of Arimoclomol in Preclinical,Stroke Recovery Studies 3CytRx Announces Positive Results of Arimoclomol in Preclinical,Stroke Recovery Studies 4CytRx Announces Positive Results of Arimoclomol in Preclinical,Stroke Recovery Studies 5
(Date:4/18/2015)... Insuranceautoquote.info has released a new blog ... quotes . , Clients can review important auto ... online environment provides important advantages for clients who need ... who do not have coverage for their vehicles can ... day or hour. Many agencies offer important discounts and ...
(Date:4/18/2015)... 18, 2015 Patients who undergo radiation ... mesothelioma later in life, but the disease is likely ... is unrelated to radiation. Surviving Mesothelioma has just posted ... Click here to read it now. , ... cases of 45 patients who had both a hematologic ...
(Date:4/18/2015)... (PRWEB) April 18, 2015 More than ... sale now at TheCelebrityDresses.com, the #1 online store carrying ... ongoing many girls have got their perfect dresses for ... the celebrity fashion prom dresses at TheCelebrityDresses.com would be ... designed more than 2000 prom dresses inspired by the ...
(Date:4/18/2015)... “ ArcAngel ” was featured on NewsWatch as ... the latest and coolest applications on the market ... AppWatch and technology expert, conducted the app review and shared ... , In a turbulent world, people may find themselves in ... be their first move, but some situations can be avoided ...
(Date:4/17/2015)... Heritage Woods of McLeansboro, a Gardant affordable assisted ... on April 20 with a day full of activities ... soul. , The community, which is located at 605 ... all incomes, including those on Medicaid, who need some ... is observed every April and highlights the communities within ...
Breaking Medicine News(10 mins):Health News:Clients Can Review Car Insurance Quotes Online To Find Low Cost Offers! 2Health News:New Study Examines Relationship Between Radiation for Hematologic Cancers and Development of Mesothelioma, According to Surviving Mesothelioma 2Health News:Prom Dresses 2015 on Sale at TheCelebrityDresses.com 2Health News:A Personal Safety Application was Featured on NewsWatch Television 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 3
... Bavarian Nordic,has received permission from the Department ... milestone payment of $25 million as allowed under ... doses of the,company,s, IMVAMUNE(R) next-generation smallpox vaccine candidate. ... of significant,milestones in the contract. The income will ...
... Paul Helmke, President,of the Brady Campaign to Prevent ... yesterday by Attorney General Michael B.,Mukasey that the ... records submitted to the Brady background check system:, ... critical need to,get all relevant records into the ...
... Information Resource Portal to ... -, NEW YORK, Nov. 30 A dynamic ... week at a,forum for healthcare journalists to tackle the ... that is of heightened public,concern due to today,s release ...
... cancer screening halves emergency admissions for the disease and significantly ... of the first UK pilot sites. , The figures, published ... carried out in Coventry and Warwickshire in the Midlands. , ... the feasibility of bowel cancer screening for those aged 50 ...
... to harm while in hospital as a result of their clinical ... , The findings are based on a review of the case ... to one large teaching hospital in the north of England during ... to be typical of other similar facilities, however, say the authors. ...
... In the final days of,November,s Lung Cancer Awareness Month, ... Health and Human Services (HHS) to,make a commitment to ... plan to address the leading cause of cancer death ... better initiative to round out our awareness,efforts this month," ...
Cached Medicine News:Health News:Bavarian Nordic Receives $25 Million Milestone Payment From HHS for Fulfilling Contract Milestones 2Health News:Bavarian Nordic Receives $25 Million Milestone Payment From HHS for Fulfilling Contract Milestones 3Health News:DOJ Report on Mental Health Records Shows Critical Need to Strengthen Brady System 2Health News:Experts Agree That One Case Is Too Many; Tackle Tough Issue of Anesthesia Awareness 2Health News:Experts Agree That One Case Is Too Many; Tackle Tough Issue of Anesthesia Awareness 3Health News:Experts Agree That One Case Is Too Many; Tackle Tough Issue of Anesthesia Awareness 4Health News:Bowel cancer screening halves emergency admissions and cuts deaths 2Health News:1 in 10 patients comes to harm while in hospital 2Health News:Lung Cancer Alliance Praises Congressional Call for Increased Commitment to Fund Lung Cancer Research 2
The Select Series® Arterial Cannulae utilize a state-of-the-art dip-molding technology. This process allows molding of a one-piece, wire-wound cannula that is flexible and kink-resistant....
Intermittent catheter...
... a rapid and accurate bedside test for the ... diagnosis and assessment of patients with suspected Congestive ... and accuracy profit from a test combining ... 12 minutes. In emergency departments Point of Care ...
... Finnpipette Focus from Thermo Labsystems was designed ... Advanced features such as the new ... adjustment on microvolumes help to define this ... pipettes. The new interchangeable handle plate offers ...
Medicine Products: